USP Salt Policy (December 2014)

FDA Drug Info Rounds pharmacists discuss the application of the United States Pharmacopeia ’s Monograph Naming Policy for Salt Drug Substances in Drug Products and Compounded Preparations (USP Salt Policy) by FDA’s Center for Drug Evaluation and Research.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news